Have you or your loved ones been diagnosed with castration-resistant prostatic cancer?

You may be eligible to participate in a castration-resistant prostatic cancer clinical trial.

Have you or your loved ones been diagnosed with castration-resistant prostatic cancer? You may be eligible to participate in a castration-resistant prostatic cancer clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Castration-Resistant Prostatic Cancer Clinical Trial in Chicago IL
NCT03016741 | Phase 4 | Interventional

Have you or your loved ones been diagnosed with castration-resistant prostatic cancer?

You may be eligible to participate in a castration-resistant prostatic cancer clinical trial.

Have you or your loved ones been diagnosed with castration-resistant prostatic cancer? You may be eligible to participate in a castration-resistant prostatic cancer clinical trial.

Recruiting

Male

18 Years +

This study is looking to recruit 100 Participants

This clinical trial studies cognitive function in men with prostate cancer treated with androgen receptor directed therapies such as abiraterone acetate and enzalutamide. The investigators use MRI imaging (non-invasive, non-contrast) to see whether there are changes in brain structure or activity related to treatment that may be related to changes in cognitive function. The investigators are also looking for genetic variations that might make patients more or less sensitive to cognitive changes during treatment for prostate cancer.